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Abstract
Background: The deleterious effects of dietary trans fatty acids (tFAs) on human health are well documented.
Although significantly reduced or banned in various countries, tFAs may trigger long-term responses that would
represent a valid human health concern, particularly if tFAs alter the epigenome.
Methods: Based on these considerations, we asked whether the tFA elaidic acid (EA; tC18:1) has any effects on global
DNA methylation and the transcriptome in cultured human THP-1 monocytes, and whether the progeny of
EA-supplemented dams during either pregnancy or lactation in mice (n = 20 per group) show any epigenetic change
after exposure.
Results: EA induced a biphasic effect on global DNA methylation in THP-1 cells, i.e. hypermethylation in the 1–50 μM
concentration range, followed by hypomethylation up to the 200 μM dose. On the other hand, the cis isomer oleic
acid (OA), a fatty acid with documented beneficial effects on human health, exerted a distinct response, i.e. its effects
were weaker and only partially overlapping with EA’s. The maximal differential response between EA and OA was
observed at the 50 μM dose. Array expression data revealed that EA induced a pro-inflammatory and adipogenic
transcriptional profile compared with OA, although with modest effects on selected (n= 9) gene promoter methylation.
In mice, maternal EA supplementation in utero or via the breastmilk induced global adipose tissue DNA hypermethylation
in the progeny, that was detectable postnatally at the age of 3 months.
Conclusion: We document that global DNA hypermethylation is a specific and consistent response to EA in cell culture
and in mice, and that EA may exert long-term effects on the epigenome following maternal exposure.
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Background
Fatty acid (FA) trans isomers (tFAs) produced by fat hy-
drogenation in the food processing industry have been
extensively linked to pathologies such as cardiovascular
disease, diabetes and obesity [1]. The pathogenic effects
of tFAs have been attributed to biochemical alterations
in cholesterol metabolism and structural changes in bio-
membranes, i.e. an increase in membrane rigidity due to
the disruption of the ordered structure of the lipid
bilayer [2]. As a result, the legislation of several coun-
tries bans or limits the content of tFA in processed food,
leading to a perceived lesser relevance for the topic of
tFAs in human health (see: www.tfx.org.uk/page116.html
for one of the earliest examples of tFA-banning laws).
Yet, FA-rich lipoproteins and individual FAs including
arachidonic, oleic and palmitic acid (AA, OA and PA,
respectively) can modify the DNA methylome [3–5]
(Silva-Martínez et al., in press), adding to a large number
of other substances identified by nutritional epigenetics
over the last decade [6, 7]. This body of evidence raises
the question whether tFAs can modify the epigenome
and therefore may exert long-term or transgenerational
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effects. To our knowledge, the effects of tFAs on DNA
methylation have not been studied, besides the intriguing
observation that the activity of the DNA methyltransferase
inhibitor azacytidine is potentiated by esterification with
the tFA elaidic acid (EA; tC18:1), suggesting that the latter
may interact with chromatin [8].
To explore that issue, we asked whether EA modifies
the DNA methylome and the transcriptome and whether
such effects are distinct from the ones elicited by its cis
isomer oleic acid (OA) in human THP-1 monocytes. We
focused on EA and OA for their biological significance,
as EA is one of the most abundant tFAs found in proc-
essed food and in circulation. Furthermore, OA has been
attributed strikingly opposite, beneficial effects on human
health compared to EA [9, 10], thus we assumed that dif-
ferential epigenetic and transcriptional signatures between
the two FAs were likely to be detectable. The rationale for
using the THP-1 cell line as model is that it has been
exploited to study the effects of lipoproteins and FAs on
the DNA methylome ([3, 11] and our group’s unpublished
data). In order to explore possible epigenetic long-term
effects, we assessed whether EA shapes the DNA methy-
lome in utero or during lactation in a mouse model. We
discuss the results in the light of the current knowledge of
FAs and disease risk.
Results
Effects of EA and OA on global DNA methylation
We first explored the effects of EA and OA on global
DNA methylation, i.e. total 5mdC content calculated by
an HPLC-based technique - in THP-1 monocytes. FAs
were used in the 1–200 μM concentration range. These
values are within the physiological range [12]. EA in-
duced a biphasic effect on global DNA methylation, i.e.
a hypermethylation in the 1–50 μM dose range corre-
sponding to a 5.2 % increase in 5mdC levels, followed by
a sharp hypomethylation up to the 200 μM dose (Fig. 1).
On the other hand, OA exerted a similarly biphasic but
weaker response peaking at 5 μM as previously reported
(Silva-Martínez et al., in press). Furthermore, the response
to OA did not significantly differ from the response
induced by the carrier BSA up to the 50 μM dose. The
maximal differential response between EA and OA was
observed at 50 μM concentration.
Whole genome expression analysis of EA- and
OA-stimulated THP-1 monocytes
In order to understand the impact of the OA- and EA-
induced changes in DNA methylation on gene expres-
sion, we performed a global genome expression analysis
using the Affymetrix GeneChip® Human Genome U133
Plus 2.0 Array in THP-1 monocytes stimulated with
50 μM of either FA for 24 h. The rationale for using
that FA concentration was that it corresponded to the
maximal differential response between EA and OA in the
global DNA methylation assay (see Fig. 1). The effects of
50 μM OA on global DNA methylation were not signifi-
cantly different from the ones of BSA alone, therefore we
only included EA- and OA-treated samples in the micro-
array analysis. Another reason for not including BSA-
treated samples, is that because of the ubiquitous and con-
tinuous presence of FAs in the circulation, cultured cells
not exposed to any FA do not have any physiological
counterpart. A total of 137 probes corresponding to 100
annotated genes met the differential expression criteria of
>2-fold absolute expression difference and p < 0.05 (t-test)
(Additional file 1: Table S1). The majority (66 or 63.5 %)
of the differentially expressed probes corresponding to an-
notated genes (104 probes, counting genes represented
more than once) were down-regulated by EA. Expression
datasets for the differentially expressed probes clearly
clustered by FA treatment (Fig. 2). The functional en-
richment analysis showed sharply distinct functions
between genes up-regulated or down-regulated by EA
(FDR < 0.05). The former were enriched in lipid biosyn-
thesis activities, whereas the down-regulated genes were
involved in cell cycle regulation (Table 1). A list of the EA-
regulated genes belonging to those two functional categor-
ies and a summary of their function is shown in Additional
file 1: Table S2. Other notable genes up-regulated by EA
were pro-inflammatory factors (IL20RB, IL21R, SLAMF7),
the cholesterol transporter ABCA1, chemokines (CCL2,
CCL4, CCL8, IL8). Up-regulated genes were not signifi-
cantly enriched for any transcription factor (TF) target cat-























Fig. 1 Effects of pure FAs on global DNA methylation in THP-1
monocytes following a 24-h stimulation. Data points represent averages
and SD values of triplicate experiments. Asterisks above or below data
points indicate the significance of the difference in comparison with the
respective 1 μM dose (*, p < 0.05; **, p < 0.01; Mann–Whitney U test).
Horizontal brackets indicate the EA or OA doses at which the response
is significantly different (p < 0.05) from the response to the vehicle BSA
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for a number of TFs including interferon regulatory factor
2 (IRF2; FDR = 6.6 × 10−7). Among IRF2 targets were the
inhibitors of inflammation myocyte enhancer factor 2C
(MEF2C) and annexin A1, (ANXA1, also known as lipo-
cortin 1), which was recently shown to decrease athero-
sclerosis in a mouse model [13–15]. The expression of a
total of 11 genes was validated by reverse transcription-
PCR (RT-PCR). Chemokines, inflammation-related and
lipid metabolism-related genes including ANXA1, CCL4
and ADFP were among the successfully validated differen-
tially expressed probes (Additional file 2: Figure S1). Next,
we asked whether any change in promoter DNA methyla-
tion was associated with differential gene expression be-
tween EA- and OA-stimulated cells. We profiled DNA
methylation in the promoters of 7 of the genes for
which expression was validated, by direct sequencing of
bisulfite-modified genomic DNA. In addition to the CpG
dinucleotide context, where methylated cytosines are pre-
dominantly found mammals, we analyzed by methylation
of cytosines located in the 5′ position of trinucleotides
with guanosine or any nucleotide at the 3′ position - i.e.
CHG or CHH, where H represents non-G nucleotides (A,
T or C). CHG and CHH methylation, although present at
low frequency, has been detected in specific cell types and
in atherosclerosis in humans, and may have regulatory
functions [16, 17]. Our results showed only weak, non-
significant changes between EA- and OA-stimulated cells
in any of three contexts analyzed. DNA methylation pro-
filing of API5 and PDK4 promoters are shown as examples
in Additional file 2: Figure S2.
Effects of EA on DNA methylation in the adipose
tissue in mice
The above data indicated that EA exerts global DNA hyper-



















Fig. 2 Clustering analysis of expression array data. Only the
differentially expressed probes are shown. The red and blue color
represent expression levels above and below the mean expression
of a gene across all six arrays, respectively. a, b and c arbitrarily
identify individual arrays according to the nomenclature used in
the GEO database- deposited material
Table 1 Functional category enrichment among genes
up-regulated or down-regulated by EA relative to OA in
THP-1 monocytes (FDR < 0.05)
GO term FDR
Up-regulated GO:0008610~lipid biosynthetic process 3.8 × 10−4
GO:0006694~steroid biosynthetic process 0.006
GO:0008202~steroid metabolic process 0.033
Down-regulated GO:0000279~M phase 0.001
GO:0022403~cell cycle phase 0.009
GO:0007049~cell cycle 0.040
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analyzed global DNA methylation in the progeny of dams
supplemented with EA either during the whole pregnancy
or lactation. The EA dose was 0.63 mg/day (0.7 μl) or the
30 g-body weight (BW) mouse equivalent of the tFA expos-
ure of a 70 kg-human eating one generic cheeseburger
every 3 days, which is slightly below recently calculated
U.S.A. figures of 3 hamburgers/week (http://www.econo
mist.com/node/154515?story_id=154515). EA did not have
any significant effects on dam’s BW during pregnancy nor
during lactation (n = 5 in each group). No adverse effects or
macroscopic anatomical abnormalities were observed, with
the exception of one case of fat necrosis in the mammary
gland of one dam that had received EA during lactation.
The progeny however, showed a significant decrease in
BW gain between birth and weaning that was significant
only in males. BW gain, calculated as percent change
compared to BW at birth, decreased by 16.6 ± 1.7 % and
10.1 ± 0.9 % in the male progeny of dams supplemented
with EA during pregnancy or lactation, respectively,
compared to controls (n = 10 for either sex in either
treatment; p < 0.05 in both cases, Scheffé’s post hoc test).
Global DNA methylation was measured in the progeny’s
abdominal adipose tissue at 3 months of age. The ration-
ale for choosing the adipose tissue was that EA alters
the adipocyte’s fat composition and physiology [18]. Data
were obtained for 3 DNA pools in each of the 4 experi-
mental groups, each pool corresponding to one litter.
EA supplementation during either pregnancy or lacta-
tion caused a significant increase in DNA methylation
(7.8 % and 14.4 %, respectively, p < 0.05, Mann–Whitney
U test; MethylFlash assay) (Fig. 3).
Discussion
We show that EA and OA exert distinct effects on global
DNA methylation in human THP-1 monocytes. These
global epigenome responses coincide with distinct whole
transcriptome profiles, but are not matched by any differ-
ence in the promoter DNA methylation of any of the tran-
scriptionally regulated genes tested. Our data suggest that
EA may target mainly either gene-body or intergenic regu-
latory element DNA methylation. Accordingly, we recently
showed that AA hypermethylates the gene-body of target
genes and members of the ALU repeated family in the
same THP-1 cell line used here (Silva-Martínez et al., in
press). At any rate, we show that maternal EA supplemen-
tation during pregnancy or lactation induces changes in
the progeny’s adipose tissue DNA methylation that are co-
directional - i.e. hypermethylation in both cases - with
the response to physiological doses of EA observed in
THP-1 cells.
The transcriptional profile induced by EA in THP-1 cells
is markedly adipogenic compared to OA, in accordance
with published data obtained with EA or trans conjugated
FAs [19, 20]. tFA-induced adipogenesis is accompanied by
hepatic steatosis [19, 21–24], which may share underlying
mechanisms with the fatty lesions observed here in one
mammary gland of EA-treated dams. The marked adipo-
genic response to EA is not reflected in a BW gain. In fact,
a sexually dimorphic, male-restricted decrease in BW was
observed in the progeny of EA-treated dams. Our data are
consistent with previous findings in models of prenatal and
adult exposure [18, 25, 26], although contrasting results
have been reported, showing no significant effect on BW
[27, 28] or an increase in primates and rodents [29–31] and
an association with obesity in humans [1]. Despite these in-
consistencies, our data suggest that the exposure to EA in
utero or during lactation slows growth in the birth-to-
weaning period. Males are more vulnerable to adverse ma-
ternal factors than females, and various mechanisms have
been proposed for this sex-specific response, including
functional differences in the immune system (extensively
reviewed in [32]). Our results do not allow to conclude
whether these effects are due to differential immunity, in-
creased catabolism or decreased appetite. In addition, based
on the enrichment of cell cycle-related genes in the tran-
scripts down-regulated by EA in THP-1 monocytes, it is
conceivable that the reduced BW gain in males may be due
at least in part to reduced cell proliferation. Interestingly,
the observation that the effects of EA on BW tended to be
more marked following supplementation during pregnancy
compared to supplmentation through breastmilk, suggested
a developmental stage-related differential vulnerability to
EA that deserves further research. At any rate, the low post-
natal growth is interesting from a clinical viewpoint, as it
may contribute to understand the association between EA
intake and increased cardiovascular risk [33–36].
Our results in THP-1 monocytes identify specific re-
sponses to EA compared to other FAs. We recently
























Fig. 3 Effect of maternal EA supplementation on the progeny’s
epididymal fat pad global DNA methylation. Data represent average
and SD for 3 replicates, each representing 8–6 mice, in all experimental
groups indicated. *, p < 0.05 (Mann–Whitney U test)
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receptor signalling pathway as a major targets in the tran-
scriptional regulation by AA and OA, whereas EA did not
modulate that pathway, nor AA or OA modulated the
lipid biosynthesis pathway (Silva-Martínez et al., in press).
In the same study, we showed by comparative genomics
that PA induces differential DNA methylation in genes
belonging to that same pathway. These genomic responses
single out EA as a biologically peculiar FA when com-
pared to AA, OA and PA, in line with the extensive
evidence linking specifically tFAs to human disease.
Conclusions
We document that the tFA EA and its cis isomer OA exert
distinct global DNA methylation and transcriptome pro-
files in cultured human cells. In addition, EA induces glo-
bal changes in the adipose tissue DNA methylome that
can be imposed by maternal exposure and are detectable
postnatally for up to 3 months in a mouse model. Our
data suggest that the deleterious effects of tFAs on human
health may extend beyond any decrease in exposure due
to legal control or voluntary abstention. However, further
studies are required in order to identify the genes involved
in EA-induced changes in the DNA methylome.
Methods
Cell culture and stimulation with FAs
THP-1 monocytes were cultured in RPMI-1640 medium
(Gibco) supplemented with 2 mM L-Glutamine (Sigma),
10 % foetal calf serum (Gibco) and 1 % Penicillin/Strepto-
mycin (Gibco). Cells were never allowed to grow above a
1–1.5 × 106 cells/ml concentration. Pure FAs (Sigma) were
conjugated with cell culture-grade FA-free BSA (fraction
V, FA-free, Sigma no. 820022) to achieve a FA:BSA 6:1 ra-
tio, essentially as described [37]. Typically, 5-6 × 106 cells
in 10 ml medium were stimulated with 100x BSA-FA mix
in 2 % FCS. Exclusion of trypan blue was used as a criter-
ion for viability.
Animal experiments
Female C57BL/6 mice were assigned to each of the follow-
ing 4 groups, n = 5 per group. 1) Supplemented with 0.7 μl
EA dissolved in 5 μl commercial soybean oil vehicle
(Nutrioli brand) orally once a day for the whole pregnancy
period, i.e. from the detection of the vaginal plug to the
day prior to delivery (20 days). 2) As in the previous group
but supplemented with vehicle alone. 3) Supplemented
with EA as in the first group but during the entire lac-
tation, i.e. between birth and weaning (28 d post par-
tum). 4) As in group 3 but with vehicle alone. Due to
the small volume, a micropipette was carefully used for
oral administrations and mice were extensively monitored
for any sign of discomfort and to ensure complete swal-
lowing. At the age of 3 months, a total of 20 progeny mice
- 10 for each sex - were randomly chosen from 3 of the
most numerous litters, 8–6 siblings/litter, and dissected
to obtain the epididymal fat pad for the downstream
analyses. The choice of the three most numerous litter
aimed at minimizing a possible effect of litter size. The
post-exposure time at dissection was therefore 3 months
and ~2 months for the pregnancy and lactation supple-
mentation groups, respectively. The procedure was ap-
proved by the Ethical Committee of the Department of
Medical Sciences of the University of Guanajuato.
Gene expression
Whole-genome expression data were obtained with the
Affymetrix GeneChip Human Genome U133 Plus 2.0.
Arrays were hybridized with labelled total RNA extracted
by using the RNeasy system (Qiagen), scanned with an
Affymetrix GeneChip Scanner 3000 according to stand-
ard protocols at the microarray facility, Rigshospitalet,
Copenhagen, Denmark. RNA integrity was checked by
agarose electrophoresis at the source laboratory and
again at the microarray facility. The dChip software (build
April 15, 2005) was used for normalization and modelling
using the PM-only model. Clustering was performed with
dChip. Expression microarray data are publicly available
in the GEO database with accession number GSE74874.
Validation was performed by RT-PCR using primers
designed with the qPrimerDepot tool (primerdepot.nci.
nih.gov). The primers listed in Additional file 1: Table S3.
DNA methylation analysis
DNA was extracted from cultured cells by standard
methods (DNeasy system, Qiagen). Global DNA methyla-
tion was measured in THP-1 cells by a HPLC-based
method yielding 5-methyl-2′-deoxycytidine (5mdC) values
normalized by 2′-deoxyguanosine (dG) [38]. Global DNA
methylation in mice was measured by the MethylFlash sys-
tem (Epigentek) according to the manufacturer’s instruc-
tions, using DNA extracted from one randomly chosen
fragment of epididymal fat pad in each animal. The assay
output is the percent 5-methyl-2′-deoxycytidine (5mdC) of
PicoGreen-quantified input genomic DNA (wt/wt). The
difference in the DNA methylation levels obtained with
the two assays is therefore explained by the distinct
normalization methods. Gene promoter DNA methyla-
tion profiling was carried out by sequencing at least 10
clones per FA treatment obtained by PCR amplification
of bisulfite-treated genomic DNA. Primers were designed
using the BiSearch tool (http://bisearch.enzim.hu) [39].
Primer sequences are listed in Additional file 1: Table S3.
Statistics
Comparisons were carried out by the Mann–Whitney U
test. The only exception was the expression array data,
where we used the t-test. The Kruskal-Wallis test followed
by the Scheffé’s ANOVA post hoc test were applied to
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compare control and treated male and female mouse data.
All tests were performed with the STATISTICA (StatSoft)
software.
Additional files
Additional file 1: Table S1. Differentially expressed probes between EA
and OA stimulated cells. Table S2. Genes differentially expressed in EA
and OA stimulated cells for the significantly enriched functional gene
categories listed in main text Table 1. Table S3. Primers used in RT-PCR
and bisulfite-modified DNA sequencing. (PDF 134 kb)
Additional file 2: Figure S1. Validation of selected expression array
data for FA-stimulated THP-1 cells. RT-PCR results are shown for the
indicated genes, performed in triplicate. Figure S2. Context-specific DNA
methylation profiling of API5 and PDK4 promoters. Contexts (CG, CHG
and CHH, where H indicates a non-G nucleotide - i.e. A, C or T. Open
bars: OA. Solid bars: EA. (PPTX 1043 kb)
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